A detailed history of Mv Capital Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Mv Capital Management, Inc. holds 41 shares of EXAS stock, worth $2,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41
Previous 2 1950.0%
Holding current value
$2,022
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$42.43 - $70.83 $1,654 - $2,762
39 Added 1950.0%
41 $2,000
Q2 2024

Aug 01, 2024

SELL
$41.33 - $74.26 $165 - $297
-4 Reduced 66.67%
2 $0
Q1 2024

Apr 18, 2024

BUY
$56.27 - $73.77 $168 - $221
3 Added 100.0%
6 $0
Q4 2023

Jan 29, 2024

BUY
$59.06 - $75.72 $177 - $227
3 New
3 $0
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $4,512 - $6,202
-50 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$93.66 - $139.27 $4,683 - $6,963
50 New
50 $6,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.